Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26K Sell
82
-200
-71% -$4.42K ﹤0.01% 2430
2026
Q1
$4.12K Sell
282
-115
-29% -$1.69K ﹤0.01% 2111
2025
Q4
$5.02K Sell
397
-840
-68% -$12.4K ﹤0.01% 1995
2025
Q3
$19K Buy
1,237
+701
+131% +$11.3K ﹤0.01% 1614
2025
Q2
$8.43K Buy
536
+412
+332% +$6.25K ﹤0.01% 1839
2025
Q1
$2.37K Buy
124
+104
+520% +$2.28K ﹤0.01% 2181
2024
Q4
$477 Hold
20
﹤0.01% 2507
2024
Q3
$560 Sell
20
-30
-60% -$847 ﹤0.01% 2466
2024
Q2
$1.31K Buy
50
+20
+67% +$416 ﹤0.01% 2269
2024
Q1
$656 Buy
+30
New +$643 ﹤0.01% 2332

Other funds holding RXO

Huntington National Bank's RXO Position: Q2 2026 in Review

Huntington National Bank reduced its RXO (RXO) stake by 71% in Q2 2026, selling an estimated $4.42K and leaving 82 shares worth $2.26K. The position accounts for ﹤0.01% of the portfolio, ranked #2430.

Huntington National Bank first reported a position in RXO in Q1 2024 and has held it in 10 quarters since. The position peaked at $19K in Q3 2025. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Huntington National Bank held 82 shares of RXO worth $2.26K as of Q2 2026.
  • Huntington National Bank sold 200 RXO shares in Q2 2026, an estimated $4.42K.
  • RXO made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2430 holding.
  • Huntington National Bank first reported a position in RXO in Q1 2024 and has held it in 10 quarters since.
  • Huntington National Bank's RXO position peaked at $19K in Q3 2025.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.